Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Capital Partners is a healthcare-focused investment and private equity firm that partners with and manages companies in the pharmaceutical and medical services sectors. The firm is most notably associated with Enovachem Pharmaceuticals, which develops and manufactures specialized drug delivery systems, including Single Use Injection Kits (SUIK) and Single Source API (SSAPI) kits. Medical Capital Partners provides the strategic and financial foundation for its portfolio companies to address gaps in the pharmaceutical supply chain and enhance patient care through innovative product combinations. The firm's leadership team consists of seasoned professionals with deep experience in pharmacy, regulatory affairs, and healthcare finance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Capital Partners.